Literature DB >> 29856880

Correction: Development of experimental GBS vaccine for mucosal immunization.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0196564.].

Year:  2018        PMID: 29856880      PMCID: PMC5983460          DOI: 10.1371/journal.pone.0198577

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is an error in Table 1. Sections within nucleotide sequences from primers A1, D1, and D2 should be bolded. The publisher apologizes for the error. Please see the corrected Table 1 here.
Table 1

Oligonucleotide primers.

PrimersDirectionNucleotide sequence from 5' to 3'
A1forwardGGGGTACCCCCGATGAGAGCAGCTGGTATTG
B1reverseCAGAATCATTTGTTTCATCAAACAATGCGCCATCATAGTTT
C1forwardTGGAGCAGGTTGAGAAGGAAGGTTCTGCGCGAGTGATAGAT
D1reverseCAACAAGCTTCAAAGCATCGTTGG
E1forwardTTGATGAAACAAATGATTCTGATG
F1reverseTTCCTTCTCAACCTGCTCCA
D2reverseCAACAGGATCCAAAGCATCGTTGG
B2forwardTGAGTGAACCACAGCCAGAA
B3forwardTCAGCAACGTGTGTCTTGGT
B4reverseCGAACCTTTACTTCGGCATC
B5reverseGTGATTCCCTTTGCTCTGC

The bold sections in the nucleotide sequences indicate the sites of restriction endonucleases used to create the design.

The bold sections in the nucleotide sequences indicate the sites of restriction endonucleases used to create the design.
  1 in total

1.  Development of experimental GBS vaccine for mucosal immunization.

Authors:  T Gupalova; G Leontieva; T Kramskaya; K Grabovskaya; E Bormotova; D Korjevski; A Suvorov
Journal:  PLoS One       Date:  2018-05-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.